Significant Shareholding

13 Oct 2008 17:19



13 October 2008

REGEN THERAPEUTICS PLC 

("ReGen" or the "Company"; Ticker: (RGT))

TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES

1.Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

ReGen Therapeutics Plc

2.Reason for the notification:

An acquisition or disposal of voting rights and an event changing the breakdown of voting rights.

3.Full name of person(s) subject to the notification obligation (iii):

Barclays PLC

4.Full name of shareholder(s) (if difference from 3):

Barclays Stockbrokers Ltd

5.Date of the transaction and date on which the threshold is crossed or reached (v):

9 October 2008

6.Date on which issued notified:

13 October 2008

7.Threshold(s) that is/are crossed or reached:

Below notifiable % to 5%

8.Notified details 

A: Voting rights attached to shares

Class/type of share if possible using the ISIN Code GB00B28XMY25

Situation Previous to the triggering transaction (vi) -

Number of Shares N/A

Number of Voting Rights (viii) N/A

Resulting situation after the triggering transaction (viii) -

Number of Shares 676,151

Number of Voting Rights - Direct (x) N/A

Number of Voting Rights - Indirect (xi) 676,151

% of voting rights - Direct N/A

% of voting rights - Indirect 5.17

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument N/A

Expiration date (xiii) N/A

Exercise/Conversion Period/Date (xiv)  N/A

Number of voting rights that may be acquired if the 

instrument is exercised/converted N/A

% of voting rights N/A

Total (A+B)

Number of voting rights 676,151

% of voting rights 5.17

9.Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Barclays Stockbrokers Ltd

Proxy Voting:

10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will cease to hold: N/A

12. Date on which proxy holder will cease to hold voting rights:   N/A

13. Additional information: N/A

14. Contact name: Geoff Smith

15.Contact telephone number: 0207 116 2913

For further information:

For further information, please contact: Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396